Will 3 cost-cutting initiatives be the cure-all for rising pharmacy costs?
Not even the clearest crystal ball could predict the impact today’s legislative and regulatory pandemonium will have on businesses. What is clear is the growing support within Congress and the Trump administration to shine a spotlight on the pharmaceutical industries’ pricing practices. What remains to be seen is how three recent initiatives will be accepted and what kind of savings can be achieved.
%20full%20color%20(29).png?width=278&height=100&name=Bukaty%20New%20logo%20(2015)%20full%20color%20(29).png)
